Brand-name drugs like Mounjaro and Zepbound undergo extensive preclinical and clinical testing before FDA approval
While the analogy of the pyloric sphincter for the stomach to the lower esophageal sphincter for the esophagus is attractive, there have been very few controlled studies in this area, and there are currently no published guidelines for pyloric therapy [130,131,132]
A second Phase 3 trial, TRANSCEND-T2D-1 (type 2 diabetes population), showed dramatically lower rates: 4.4% at 12 mg
Its active ingredient, semaglutide, is also used in Wegovy, a higher-dose medication approved specifically for weight management
GoGoMeds received a resolved 2019 administrative order (a $1,000 fine for an out-of-state supervision issue), now closed with no further actions
Many plans cover Victoza for type 2 diabetes when metformin monotherapy has been inadequate